Samsung Group, Quintiles Plan $266 Million Venture to Make Biologic Drugs

Samsung Group, the South Korean company whose businesses range from electronics to ship-building, will partner with Quintiles Transnational Corp. to make biologic drugs as it seeks new businesses to drive growth.
Bloomberg